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Background/Introduction
Surgical management of empyema remains a necessity
in the modern era. In many cases the patients are
already on anti-microbial therapy prior to referral for
definitive surgical management. Surgeons will send sam-
ples during the operative case for analysis, but in the
setting on ongoing microbiological therapy, these may
not prove rewarding.
Aims/Objectives
We examine the utility of intra-operative microbiology
sampling in the setting of thoracic empyema.
Method
A retrospective review of data for patients undergoing dec-
ortication for diagnosed stage III empyema was ascertained
via prospectively recorded data. Histopathology and culture
records were obtained from January 2011 to December
2014. A total of 67 cases were included. The study focused
on intra-operative samples taken for microbiological analy-
sis, cytology and histopathology. Material was obtained
from broncho-alveolar-lavage samples, wound swabs,
pleural fluid analysis and decorticated material.
Results
Of the total of 67 patients, 1 was incidentally found to
have a mesothelioma. Of the remaining 66, 25.7% (17)
patients were found to have positive cultures from corti-
cal samples, however 7 of these patients had no growth
from concomitant pleural fluid samples. 74.2% were
found to be culture negative. In five cases multiple
organisms were cultured. The most common species
was Staphylocci spp. in 7 colonies (41.1%), Gram nega-
tive rods including Escherichia coli, Pseudomonas spp,
Klebsiella in 4 colonies (23.5%), there were 2 patients of
Corynebacterium spp and 1 of Aspergillus fumigatus.
2 cases of Mycobacterium tuberculosis, diagnosed on
both cultures and confirmed by histopathology, had no
growths from pleural fluid.
Discussion/Conclusion
A significant number of patients had positive cultures. In
addition a neoplastic case and TB were identified when
not suspected. It remains a recommendation that all
patients with surgical decortication should have culture
samples and that we must take into account the changing
microbiology spectrum when considering antibiotic ther-
apy in earlier stages of empyema thoracis.
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